A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia
Clinical trial NCT01968980 · COMPLETED
Trial details
- NCT number
- NCT01968980
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-23
- Primary completion
- 2016-04-15
- Enrollment
- 370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.